78 results
8-K
EX-99.1
ACST
Acasti Pharma Inc - Ordinary Shares
27 Jun 24
Acasti Announces Achievement of 50% Enrollment in Pivotal Phase 3 STRIVE-ON Safety Trial
4:10pm
of such bleeding is the rupture of an aneurysm. Approximately 70% of aSAH patients experience death or dependence, and more than 30% die within one month
8-K
EX-99.1
ACST
Acasti Pharma Inc - Ordinary Shares
21 Jun 24
Acasti Announces Year-End 2024 Financial Results, Provides Business Update
8:00am
that supply the brain. A primary cause of such bleeding is the rupture of an aneurysm. Approximately 70% of aSAH patients experience death or dependence
8-K
EX-99.1
zepsrtaefkiw6rjmcnog
1 Apr 24
Regulation FD Disclosure
8:00am
8-K
EX-99.1
cfslxgr
12 Feb 24
Acasti Announces Third Fiscal Quarter 2024 Financial Results and Business Highlights
8:00am
8-K
EX-99.1
eoeet0a drpinmjdm
13 Nov 23
Acasti Announces Second Quarter 2024 Financial Results and Business Highlights
12:00am
8-K
EX-99.1
ah5n2g4s
23 Oct 23
Acasti Announces Dosing of First Patient in GTX-104 STRIVE-ON Trial
4:30pm
8-K
EX-99.1
2y4hslb9zx8ku zkta
11 Aug 23
Acasti Announces First Quarter 2024 Financial Results and Business Highlights
7:31am
8-K
EX-99.1
6iue2uxf6po
5 Jul 23
Other Events
4:00pm
8-K
EX-99.2
7bt rcih3
5 Apr 23
Acasti Announces Appointment of Prashant Kohli as CEO
5:00pm